RU.521 - An Overview
Benefits of the next comparative examine ended up reported by Flinn et al. This can be a phase III randomized Intergroup trial comparing FC regimen compared to FAMP by yourself in 278 people acquiring their initial chemotherapy regimen for B-CLL. Dosages of FC plan had been the same as the primary review.If you or your husband or wife becomes Expec